These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 29775390)

  • 1. Polarization and Distribution of Tumor-Associated Macrophages and COX-2 Expression in Basal Cell Carcinoma of the Ocular Adnexae.
    Kaiser U; Loeffler KU; Nadal J; Holz FG; Herwig-Carl MC
    Curr Eye Res; 2018 Sep; 43(9):1126-1135. PubMed ID: 29775390
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunology and growth characteristics of ocular basal cell carcinoma.
    Rohrbach JM; Stiemer R; Mayer A; Riedinger C; Duijvestijn A; Zierhut M
    Graefes Arch Clin Exp Ophthalmol; 2001 Jan; 239(1):35-40. PubMed ID: 11271459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of p16 Protein in Cutaneous Basal Cell Carcinoma: Still far from Being Clearly Understood.
    Bartoš V
    Acta Dermatovenerol Croat; 2020 Jul; 28(1):43-44. PubMed ID: 32650852
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Increased expression of COX-2 in recurrent basal cell carcinoma of the skin: a pilot study.
    Karahan N; Baspinar S; Bozkurt KK; Caloglu E; Ciris IM; Kapucuoglu N
    Indian J Pathol Microbiol; 2011; 54(3):526-31. PubMed ID: 21934214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution and presumed proliferation of macrophages in inflammatory diseases of the ocular adnexae.
    Herwig MC; Holz FG; Loeffler KU
    Curr Eye Res; 2015 May; 40(6):604-10. PubMed ID: 25111002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophage subtypes in recurrent nodular basal cell carcinoma after Mohs micrographic surgery.
    Padoveze EH; Chiacchio ND; Ocampo-Garza J; Cernea SS; Belda W; Sotto MN
    Int J Dermatol; 2017 Dec; 56(12):1366-1372. PubMed ID: 28994114
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-associated macrophage-induced invasion and angiogenesis of human basal cell carcinoma cells by cyclooxygenase-2 induction.
    Tjiu JW; Chen JS; Shun CT; Lin SJ; Liao YH; Chu CY; Tsai TF; Chiu HC; Dai YS; Inoue H; Yang PC; Kuo ML; Jee SH
    J Invest Dermatol; 2009 Apr; 129(4):1016-25. PubMed ID: 18843292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal cell carcinoma of the skin with mixed histomorphology: a comparative study.
    Bartoš V; Kullová M
    Cesk Patol; 2016; 52(4):222-226. PubMed ID: 27869450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased immunoreactivity of membrane type-1 matrix metalloproteinase (MT1-MMP) and β-catenin in high-risk basal cell carcinoma.
    Oh ST; Kim HS; Yoo NJ; Lee WS; Cho BK; Reichrath J
    Br J Dermatol; 2011 Dec; 165(6):1197-204. PubMed ID: 21729023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Immunoexpression of p53 and COX-2 in basal cell carcinoma.
    Enache AO; Stepan AE; Mărgăritescu C; Pătraşcu V; Ciurea RN; Simionescu CE; Camen A
    Rom J Morphol Embryol; 2018; 59(4):1115-1120. PubMed ID: 30845292
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sebaceous gland carcinoma of the ocular adnexa - variability in clinical and histological appearance with analysis of immunohistochemical staining patterns.
    Schmitz EJ; Herwig-Carl MC; Holz FG; Loeffler KU
    Graefes Arch Clin Exp Ophthalmol; 2017 Nov; 255(11):2277-2285. PubMed ID: 28741159
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of cyclooxygenase 2 and peroxisome proliferator-activated receptor γ in eyelid sebaceous gland carcinoma.
    Jayaraj P; Sen S; Bhattacharya T; Arora J; Yadav S; Chhoker V; Kumar A; Dhanaraj PS; Yadavilli KS; Verma M
    Histopathology; 2016 Aug; 69(2):268-75. PubMed ID: 26791964
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Basal cell carcinoma progression correlates with host immune response and stromal alterations: a histologic analysis.
    Kaur P; Mulvaney M; Carlson JA
    Am J Dermatopathol; 2006 Aug; 28(4):293-307. PubMed ID: 16871032
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunohistochemical Expression of Calponin in Cutaneous Basal Cell Carcinoma.
    Bartoš V; Kullová M
    Acta Dermatovenerol Croat; 2015; 23(4):254-9. PubMed ID: 26724876
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical nuclear staining for p53, PCNA, and Ki-67 in different histologic variants of basal cell carcinoma.
    Barrett TL; Smith KJ; Hodge JJ; Butler R; Hall FW; Skelton HG
    J Am Acad Dermatol; 1997 Sep; 37(3 Pt 1):430-7. PubMed ID: 9308559
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histological characteristics of basal cell carcinoma of the eyelid.
    Paavilainen V; Aaltonen M; Tuominen J; Saari KM
    Ophthalmic Res; 2007; 39(1):45-8. PubMed ID: 17164577
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Actin expression in purely nodular versus nodular-infiltrative basal cell carcinoma.
    Law AM; Oliveri CV; Pacheco-Quinto X; Horenstein MG
    J Cutan Pathol; 2003 Apr; 30(4):232-6. PubMed ID: 12680952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and Factors Related to Eyelid Basal Cell Carcinoma in Saudi Arabia.
    Al Wohaib M; Al Ahmadi R; Al Essa D; Maktabbi A; Khandekar R; Al Sharif E; Al Katan H; Schellini SA; Al Shaikh O
    Middle East Afr J Ophthalmol; 2018; 25(2):96-102. PubMed ID: 30122855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Histological subtypes of periocular basal cell carcinoma.
    Wu A; Sun MT; Huilgol SC; Madge S; Selva D
    Clin Exp Ophthalmol; 2014; 42(7):603-7. PubMed ID: 24533627
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.